ATP synthase is a multisubunit complex comprising F1 (catalytic) and F0 (proton channel) sectors. Subunit a (atpB) in the F0 sector facilitates proton flow across the membrane, driving ATP synthesis via rotational catalysis . Key structural motifs include:
In Campylobacter, ATP synthase is vital for microaerobic survival, enabling adaptation to host gastrointestinal environments .
Antibiotic Resistance Studies: ATP synthase is a potential target for efflux pump inhibitors, as seen in C. jejuni CmeB .
Structural Biology: Used in crystallography to map proton channel dynamics .
Metabolic Studies: Investigating ATP dependency in Campylobacter’s microaerobic metabolism .
The atpB gene is conserved across Campylobacter species but shows phylum-specific variations in ATP synthase oligomerization .
In C. curvus, atpB clusters with C. jejuni and C. coli in multilocus sequence typing (MLST), suggesting lateral gene transfer events .
KEGG: ccv:CCV52592_0790
STRING: 360105.CCV52592_0790
ATP synthase subunit a (atpB) is a critical component of the F₀ sector of the ATP synthase complex in Campylobacter curvus. This membrane-embedded protein forms part of the proton channel that couples the proton motive force (PMF) to ATP synthesis. The full-length protein consists of 225 amino acids in C. curvus and functions within the multisubunit ATP synthase complex to facilitate energy conversion processes. As a membrane protein, it contains hydrophobic regions that anchor it within the bacterial membrane, where it participates in the rotary mechanism that drives ATP synthesis through proton translocation across the membrane.
The protein is particularly important for energy metabolism in Campylobacter species, which as microaerophilic organisms must efficiently utilize available energy sources. ATP synthase operates by harnessing the proton gradient generated by respiratory complexes to synthesize ATP from ADP and inorganic phosphate, making atpB essential for bacterial energy production and survival in various environments.
The recombinant expression of C. curvus atpB typically employs E. coli as the host organism due to its well-established genetic tools and rapid growth. For optimal expression, the atpB gene (UniProt ID: A7GYS2) is generally fused to an N-terminal His-tag to facilitate purification and detection. The protein is expressed as a full-length construct spanning amino acids 1-225 of the native sequence.
The purification methodology typically follows these steps:
Expression in an appropriate E. coli strain under optimal induction conditions
Cell lysis using methods suitable for membrane proteins (e.g., sonication, French press)
Solubilization of membrane fractions using detergents like DDM or CHAPS
Affinity chromatography using Ni-NTA or similar matrices to capture the His-tagged protein
Size exclusion chromatography for further purification
This approach yields recombinant protein suitable for structural and functional studies, although the membrane-associated nature of atpB presents challenges that may require optimization of solubilization and purification conditions.
For long-term stability of recombinant C. curvus atpB, the following storage conditions are recommended:
Store the lyophilized powder at -20°C/-80°C upon receipt
After reconstitution, add 5-50% glycerol (final concentration) to prevent freeze damage
Aliquot the protein solution to minimize freeze-thaw cycles
For working solutions, store at 4°C for up to one week
Avoid repeated freeze-thaw cycles as they significantly reduce protein stability and activity
When reconstituting the protein, use deionized sterile water to achieve a concentration of 0.1-1.0 mg/mL. The protein is typically stored in a Tris/PBS-based buffer at pH 8.0 containing 6% trehalose, which helps maintain protein stability during freeze-thaw cycles. The presence of glycerol (typically 50% final concentration) further protects the protein structure during freezing.
To investigate functional interactions between C. curvus atpB and other ATP synthase subunits, several methodological approaches are recommended:
Co-expression and co-purification systems:
Design constructs for co-expression of atpB with interacting subunits
Implement dual affinity tags for sequential purification of intact complexes
Optimize detergent conditions to maintain native-like subunit interactions
Cross-linking coupled with mass spectrometry (XL-MS):
Apply chemical cross-linkers to stabilize transient interactions
Digest cross-linked complexes and analyze by LC-MS/MS
Use computational tools to map interaction interfaces from cross-linked peptides
FRET-based interaction assays:
Engineer fluorescent protein fusions to atpB and potential interaction partners
Measure energy transfer as indicator of molecular proximity
Conduct competition assays to validate specificity of interactions
Bacterial two-hybrid systems:
Adapt adenylate cyclase-based two-hybrid systems for membrane protein interactions
Screen for interactions between atpB and other ATP synthase components
Validate positive hits with alternative interaction assays
When studying membrane protein interactions like those involving atpB, it's critical to maintain a membrane-like environment using appropriate detergents or lipid nanodiscs to preserve native conformations and interaction capabilities.
Developing a robust screening platform for identifying atpB inhibitors requires systematic methodological approaches:
Establishment of functional assays:
Develop ATP synthesis assays using reconstituted proteoliposomes containing purified ATP synthase complex
Implement proton translocation assays using pH-sensitive fluorescent dyes
Design ATPase activity assays as a reverse reaction indicator
Structure-based virtual screening:
Generate homology models of C. curvus atpB based on related structures
Identify potential binding pockets using computational algorithms
Perform virtual screening of compound libraries against these pockets
Select candidates for experimental validation based on predicted binding energies
Fragment-based screening approaches:
Screen small molecular fragments for binding to purified atpB
Use thermal shift assays, surface plasmon resonance, or NMR to detect binding
Elaborate promising fragments into larger inhibitors
Validation in bacterial systems:
Test candidate inhibitors in C. curvus growth assays
Confirm target engagement using resistant mutants or overexpression studies
Evaluate specificity by testing against ATP synthases from different species
Assessing antimicrobial potential:
Determine minimum inhibitory concentrations (MICs)
Conduct time-kill studies to characterize bactericidal vs. bacteriostatic effects
Evaluate potential for resistance development through serial passage experiments
This systematic approach enables identification of atpB inhibitors that could serve as leads for novel antimicrobials against Campylobacter infections, which is particularly valuable given the emerging antibiotic resistance in these pathogens.
The expression of functional recombinant C. curvus atpB requires careful consideration of expression systems and conditions to overcome challenges associated with membrane protein production:
| Expression System | Advantages | Challenges | Optimization Strategies |
|---|---|---|---|
| E. coli BL21(DE3) | High yield, simple genetics, rapid growth | Inclusion body formation, toxicity | Lower induction temperature (16-20°C), weak promoters, specialized strains (C41/C43) |
| E. coli Lemo21(DE3) | Tunable expression, membrane protein-friendly | Higher complexity | Optimization of L-rhamnose concentration for expression tuning |
| Cell-free systems | Avoids toxicity issues, direct incorporation into liposomes | Lower yields, higher cost | Supplementation with lipids/detergents, optimized extract preparation |
| Yeast systems | Post-translational modifications, eukaryotic machinery | Longer growth times, different codon usage | Codon optimization, selection of appropriate promoters |
For C. curvus atpB specifically, E. coli expression systems have proven successful when the protein is fused to an N-terminal His tag. The expression protocol should include:
Induction at lower temperatures (16-20°C) to slow protein synthesis and facilitate proper folding
Use of specialized E. coli strains designed for membrane protein expression
Careful optimization of inducer concentration to prevent toxicity
Addition of membrane-stabilizing compounds (glycerol, specific lipids) to the culture medium
Extended expression times (overnight to 24 hours) at lower temperatures
The resulting protein can be purified to >90% purity using appropriate chromatographic techniques and verified by SDS-PAGE.
Multiple complementary analytical approaches are necessary to comprehensively characterize recombinant C. curvus atpB:
Structural integrity assessment:
Circular dichroism (CD) spectroscopy to verify secondary structure composition
Limited proteolysis coupled with mass spectrometry to probe folding quality
Fluorescence spectroscopy to assess tertiary structure through intrinsic tryptophan fluorescence
Size exclusion chromatography with multi-angle light scattering (SEC-MALS) to determine oligomeric state
Functional activity assessment:
Proton translocation assays using reconstituted proteoliposomes and pH-sensitive dyes
ATP synthesis assays when incorporated into complete ATP synthase complexes
Binding assays with known ATP synthase inhibitors using isothermal titration calorimetry (ITC)
Hydrogen utilization assays in reconstituted systems, given the importance of hydrogen metabolism in Campylobacter species
Membrane integration analysis:
Proteoliposome reconstitution efficiency determination
Fluorescence quenching assays to assess membrane insertion
Electron microscopy of reconstituted systems to visualize membrane incorporation
Interaction studies:
Pull-down assays with other ATP synthase subunits
Native gel electrophoresis to assess complex formation
Surface plasmon resonance (SPR) to measure binding kinetics with interaction partners
These methodologies collectively provide a comprehensive assessment of both the structural integrity and functional capability of the purified recombinant protein, essential for ensuring reliable results in downstream applications.
Site-directed mutagenesis represents a powerful approach to investigate structure-function relationships in C. curvus atpB. A systematic experimental design should include:
Target selection based on structural and evolutionary analysis:
Identify conserved residues through multiple sequence alignment of atpB across bacterial species
Focus on residues in predicted proton channels or subunit interfaces
Consider residues with known functional importance in homologous proteins
The full amino acid sequence (MKDLFLFSDLIYHNHLFVYAFHFCLVAIIVVLVAKLATSKMQLVPRGLQNIVEAYLEGVISMGRDTLGSEALARKYLPLVATIGFVVFFSNAIGIIPGFESPTSSLNLTLTLALIVFFYYHFEGIKKNGFFKYFGHFMGPSKALAPLMFPVEIISHLSRIVSLSFRLFGNIKGDDLFLLVMLTLAPWFAPLPAYALLTLMAVLQTFIFMMLTYVYLAGAVAIEEH) provides a basis for selecting mutation targets
Mutation strategy development:
Design conservative mutations (similar physicochemical properties) to probe subtle functional effects
Create non-conservative mutations to dramatically alter local properties
Generate alanine-scanning mutations across functionally important regions
Introduce cysteine pairs for disulfide cross-linking to test proximity relationships
Functional characterization methodologies:
Compare wild-type and mutant proteins for proton translocation efficiency
Assess ATP synthesis rates in reconstituted systems
Measure binding affinities with other ATP synthase subunits
Determine structural changes using spectroscopic methods
Evaluate hydrogen utilization capacity, given the importance of hydrogen metabolism in related Campylobacter species
Experimental controls and validation:
Express and purify mutants alongside wild-type protein using identical conditions
Verify structural integrity of mutants using CD spectroscopy and thermal stability assays
Include positive and negative control mutations based on existing knowledge
Validate key findings with complementary approaches (e.g., complementation studies in bacteria)
This comprehensive approach enables researchers to systematically dissect the functional mechanisms of C. curvus atpB, contributing to our understanding of ATP synthase function and potentially identifying sites for therapeutic intervention.
The relationship between C. curvus atpB and bacterial hydrogen metabolism represents an emerging area of research with significant implications for understanding pathogenesis:
Campylobacter species, including C. jejuni and C. concisus, utilize hydrogen as an energy source in the gastrointestinal environment. This molecular hydrogen (H₂) is abundantly produced by colonic microbiota at concentrations of approximately 168 μM in the small intestine and 43 μM in the stomach, far exceeding the apparent affinities of most pathogens for H₂ (1.8 to 2.5 μM).
The ATP synthase complex, of which atpB is a critical component, plays a central role in this energy harvesting system. The process operates as follows:
Hydrogenase enzymes cleave H₂ into electrons and protons
The derived protons contribute to the proton motive force (PMF)
Electrons enter aerobic or anaerobic respiratory chains
The resulting PMF drives ATP synthesis via the ATP synthase complex containing atpB
Research has demonstrated that hydrogen metabolism is critical for growth and virulence in several gastrointestinal pathogens, including C. jejuni. The regulatory mechanisms controlling ATP synthase expression are complex, with various signals and regulators affecting hydrogenase operon expression, including:
Redox state (regulated by factors such as ArcA)
Oxygen levels (regulated by factors such as FNR)
Energy availability (regulated by factors such as CRP)
Metal availability (regulated by factors such as Fur and NikR)
For C. curvus specifically, the atpB component of ATP synthase likely plays a crucial role in harnessing the energy derived from hydrogen metabolism, contributing to the organism's ability to colonize the gastrointestinal tract and potentially to its pathogenicity. This connection between hydrogen metabolism, ATP synthesis, and pathogenesis represents an important area for further investigation.
Comparative analyses of C. curvus atpB can provide valuable insights into its evolution and functional adaptations through several methodological approaches:
Phylogenetic analysis across Campylobacter species:
Construct maximum-likelihood phylogenetic trees using atpB sequences
Identify clades with accelerated evolutionary rates
Map evolutionary relationships against known pathogenicity patterns
Compare evolutionary rates of atpB versus other ATP synthase subunits
Selection pressure analysis:
Calculate dN/dS ratios across the protein sequence
Identify sites under positive selection that may indicate functional adaptation
Compare selection patterns between pathogenic and non-pathogenic Campylobacter species
Correlate selection patterns with predicted functional domains
Structural homology modeling and comparison:
Generate structural models based on homologous proteins with known structures
Compare predicted structures across Campylobacter species
Identify conserved structural elements versus variable regions
Map conservation patterns onto functional domains (e.g., proton channel, subunit interfaces)
Functional domain analysis in the context of hydrogen metabolism:
Such comprehensive comparative analyses can reveal how C. curvus atpB has adapted to specific environmental niches, potentially contributing to pathogenicity, and may identify regions of the protein that could serve as targets for species-specific inhibitors.
Investigating C. curvus atpB within the full ATP synthase complex requires specialized methodological approaches:
Co-expression and purification strategies:
Design polycistronic expression systems encoding multiple ATP synthase subunits
Implement dual affinity tags for sequential purification of intact complexes
Optimize detergent and lipid conditions to maintain complex integrity
Consider cell-free expression systems for direct incorporation into liposomes
Structural characterization of the complex:
Cryo-electron microscopy for high-resolution structural determination
Cross-linking mass spectrometry to map subunit interfaces
Hydrogen-deuterium exchange mass spectrometry to probe dynamics and accessibility
Single-particle analysis to capture different conformational states
Functional reconstitution systems:
Proteoliposome reconstitution with purified ATP synthase complexes
Establishment of proton gradients using ionophores or light-driven pumps
Real-time monitoring of ATP synthesis and proton translocation
Patch-clamp studies to measure proton conductance through F₀ complexes
In vivo analysis approaches:
Generation of complementation systems in ATP synthase-deficient strains
Construction of chimeric ATP synthases to test subunit compatibility
Site-specific incorporation of fluorescent probes for FRET studies
Hydrogen utilization assays in intact cells, given the connection between hydrogen metabolism and ATP synthesis in Campylobacter species
Regulatory analysis:
Investigation of transcriptional regulation under different growth conditions
Analysis of post-translational modifications affecting complex assembly or function
Study of protein-protein interactions using bacterial two-hybrid or split-GFP systems
These approaches collectively provide a comprehensive toolkit for studying C. curvus atpB within its native complex, essential for understanding its true physiological function and potential as an antimicrobial target.
Researchers face several significant challenges when attempting to produce recombinant C. curvus atpB in quantities and quality suitable for structural studies:
Membrane protein expression limitations:
Low expression levels compared to soluble proteins
Toxicity to host cells when overexpressed
Misfolding and aggregation in heterologous systems
Challenges in scaling up production
Purification and stability challenges:
Requirement for detergents that may destabilize the protein
Loss of native lipid interactions that stabilize structure
Limited stability after extraction from membranes
Difficulty maintaining functional state during concentration
Methodological approaches to overcome these challenges:
Implementation of specialized E. coli strains (C41/C43, Lemo21)
Use of fusion partners (MBP, SUMO) to enhance solubility
Screening of expression conditions (temperature, induction time, media composition)
Testing of multiple detergents and lipid supplements during purification
Addition of stabilizers (glycerol, specific lipids, trehalose) to buffers
Advanced expression systems to consider:
Cell-free systems supplemented with lipids or nanodiscs
Specialized yeast strains optimized for membrane protein expression
Baculovirus-insect cell systems for eukaryotic processing machinery
Nanodiscs or SMALPs (styrene-maleic acid lipid particles) to maintain native-like environment
The development of effective expression and purification protocols for C. curvus atpB represents a crucial foundation for structural and functional studies that can inform our understanding of ATP synthase function and potential therapeutic interventions in Campylobacter infections.
Bridging the gap between in vitro biochemical studies and in vivo relevance requires multidisciplinary approaches:
Genetic manipulation strategies:
Construction of atpB knockout and complementation systems
Development of conditional expression systems to control atpB levels
Creation of site-directed mutants based on in vitro findings
Implementation of chromosomal tags for tracking protein localization
Infection model systems:
Establishment of cell culture models for Campylobacter infection
Development of animal models that recapitulate human infection
Ex vivo organ culture systems to study tissue-specific effects
Microfluidic devices to simulate host microenvironments
Physiological assessment methodologies:
Integrative analytical approaches:
Transcriptomic analysis to identify gene expression networks affected by atpB function
Metabolomic profiling to assess metabolic shifts in atpB mutants
Proteomics to identify interaction partners and post-translational modifications
Systems biology modeling to integrate biochemical and physiological data
Correlation with clinical observations:
Analysis of atpB sequence variations in clinical isolates
Assessment of ATP synthase activity in strains with different virulence profiles
Investigation of atpB expression during different stages of infection
Examination of host immune responses to ATP synthase components
These approaches collectively enable researchers to connect molecular findings about C. curvus atpB structure and function with its broader role in bacterial physiology and pathogenesis, potentially identifying new therapeutic strategies for Campylobacter infections.
Several cutting-edge technologies hold promise for deepening our understanding of C. curvus atpB:
Advanced structural biology techniques:
Cryo-electron tomography for visualizing ATP synthase in native membranes
Micro-electron diffraction (microED) for structural determination from small crystals
Integrative structural biology combining multiple data sources (SAXS, NMR, XL-MS)
Time-resolved structural methods to capture dynamic conformational changes
Single-molecule approaches:
High-speed atomic force microscopy to visualize ATP synthase rotation
Single-molecule FRET to track conformational dynamics
Optical tweezers to measure force generation by the ATP synthase complex
Nanopore recording of proton translocation through individual channels
Advanced genetic technologies:
CRISPR interference for precise regulation of atpB expression
In vivo mutagenesis libraries to probe function comprehensively
Proximity labeling approaches to map protein interaction networks
Synthetic biology approaches to create minimal ATP synthase systems
Computational advances:
Drug discovery technologies:
Fragment-based drug discovery using NMR or crystallography
DNA-encoded libraries for high-throughput screening
Structure-based virtual screening against multiple conformational states
Activity-based protein profiling to identify selective inhibitors
These emerging technologies, applied individually or in combination, have the potential to significantly advance our understanding of C. curvus atpB structure, function, and its role in bacterial pathogenesis, ultimately informing the development of novel therapeutic strategies targeting ATP synthase in Campylobacter infections.
The current state of knowledge about C. curvus atpB suggests several high-priority research directions that could significantly advance the field:
Structure-function relationship studies:
Determination of high-resolution structures of C. curvus atpB in different conformational states
Mapping of the proton translocation pathway through the membrane domain
Investigation of subunit interactions within the ATP synthase complex
Correlation of structural features with energy coupling efficiency
Pathogenesis and virulence connections:
Exploration of the link between ATP synthase function and Campylobacter pathogenicity
Investigation of atpB expression regulation during different stages of infection
Analysis of the relationship between hydrogen metabolism and ATP synthase activity
Assessment of host immune responses to ATP synthase components
Therapeutic targeting approaches:
Design of specific inhibitors targeting unique features of C. curvus atpB
Development of combination therapies targeting energy metabolism pathways
Investigation of natural products with activity against ATP synthase
Exploration of atpB as a potential vaccine antigen
Evolutionary and comparative studies:
Comparative analysis of atpB across Campylobacter species with different pathogenicity profiles
Investigation of horizontal gene transfer and recombination events in atpB evolution
Study of co-evolution patterns between atpB and other ATP synthase subunits
Examination of selection pressures on atpB in different ecological niches
These research directions hold particular promise for advancing our understanding of C. curvus biology and potentially developing new strategies for combating Campylobacter infections.
To enhance research reproducibility when working with this challenging membrane protein, researchers should consider implementing these methodological recommendations:
Standardized expression and purification protocols:
Document detailed protocols including strain genotypes, plasmid maps, and expression conditions
Specify exact buffer compositions, including detergent types, concentrations, and critical micelle concentrations
Report protein yields at each purification step with representative gel images
Validate protein identity through mass spectrometry and N-terminal sequencing
Comprehensive quality control measures:
Implement multiple purity assessment methods beyond SDS-PAGE (e.g., SEC-MALS, dynamic light scattering)
Verify protein folding through circular dichroism and fluorescence spectroscopy
Assess oligomeric state using analytical ultracentrifugation or native PAGE
Conduct functional assays to confirm biological activity of purified protein
Detailed reporting of experimental conditions:
Specify temperature, pH, buffer composition, and ionic strength for all experiments
Document protein concentration determination methods and standards used
Report storage conditions and demonstrate stability over the experimental timeframe
Include positive and negative controls in all functional assays
Data management and sharing practices:
Deposit sequence data in public databases with appropriate annotation
Share raw data through repositories like Zenodo or figshare
Provide detailed supplementary methods sections in publications
Consider pre-registration of experimental designs for key studies
Adherence to these recommendations will significantly enhance the reproducibility of research involving recombinant C. curvus atpB, accelerating scientific progress and facilitating more effective collaboration across research groups.
Research on C. curvus atpB has the potential to impact several broader scientific and medical fields:
Antimicrobial development:
Identification of novel binding sites for ATP synthase inhibitors
Development of narrow-spectrum antibiotics targeting Campylobacter-specific features
Creation of combination therapies targeting energy metabolism pathways
Design of anti-virulence strategies that disrupt ATP synthase function without killing bacteria
Fundamental bioenergetics research:
Deeper understanding of proton translocation mechanisms
Insights into the evolution of ATP synthases across diverse bacteria
Clarification of structure-function relationships in membrane protein complexes
Elucidation of regulatory mechanisms controlling energy metabolism
Microbiome science applications:
Understanding how energy metabolism influences bacterial community dynamics
Development of approaches to selectively target pathogenic Campylobacter while sparing beneficial microbiota
Potential prebiotic or probiotic strategies to modulate hydrogen availability
Biotechnological applications:
Engineering of ATP synthase components for enhanced efficiency in biotechnological processes
Development of biosensors based on ATP synthase components
Creation of minimal ATP synthase systems for synthetic biology applications
Potential applications in biofuel cell development